Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01721226 · ClinicalTrials.gov registry record · NA
CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT01721226: Completed NA study, sponsored by George Washington University.
NCT01721226 is a NA study that has completed, run by George Washington University. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01721226, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an intervention (CARE+ Corrections) delivered to HIV-infected detainees within the DC Department of Corrections (DOC) and recently -released ex-detainees in the community can improve linkage to community HIV care and adherence to HIV medications after release, and ultimately achieve or maintain HIV viral suppression following community re-entry.
Primary Outcome
Plasma viral load at 24 weeks measured by viral load testing or medical chart abstraction
Interventions
- DEVICE Intervention Arm (computer-based CARE+ Corrections tool)
- OTHER Educational video on opiate overdose prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT01721226 record still lists
NCT01721226 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Intervention Arm (computer-based CARE+ Corrections tool) is the first listed.
NCT01721226 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01721226 about?
NCT01721226 is a clinical study titled "CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)". The purpose of this study is to determine whether an intervention (CARE+ Corrections) delivered to HIV-infected detainees within the DC Department of Corrections (DOC) and recently -released ex-detainees in the community can improve linkage to community HIV care and adherence to HIV medications afte...
What is the current status of trial NCT01721226?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2013-08. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01721226?
The interventions under investigation include: Intervention Arm (computer-based CARE+ Corrections tool) (DEVICE), Educational video on opiate overdose prevention (OTHER).
Who is sponsoring clinical trial NCT01721226?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01721226's enrollment target sits among peer trials
112 813th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia